5/29/20
By Niloofer Shaikh, SeekingAlpha
Venrock Healthcare Capital Partners acquired an aggregate 1.3M common shares of Altimmune (NASDAQ:ALT) at a weighted average price ranging from $8.40 to $9.39.
The fund now owns 3M shares of the company.
ALT +16.1% premarket.
READ FULL ARTICLE HERE
David S. Brown Enterprises has bolstered its Retail Leasing team with the recent hiring of Michael Gosnell
The Virginia law firm Gentry Locke is pleased to announce the promotion of Scott A. Stephenson to
Pessin Katz Law is pleased to announce that Attorney Adam E. Konstas has been elected to Member
Skanska, a leading global construction and development firm, announces that Gary Orton has joined the company as